By rray, 14 June, 2024 Exclude Patient Type Detail Header No Detail Type Text Detail Text Residual lifetime risk 20 as defined by models that are largely dependent on FHx3 6 Rad tx w exposure to breast tissue between ages 10 30 yo3 Atypical ductal hyperplasia ADH and 20 residual lifetime risk3 LCIS ALH and 20 residual lifetime risk3 Pedigree suggestive of or known genetic predisposition3 Known breast cancer gene based on genetic testing 6 7 Candidate genes 7 BRCA1 2 ATM BARD1 BRIP1 CDH1 CHEK2 NF1 PALB2 PTEN Cowden syndrome RAD51C RAD51D STK11 TP53 Li Fraumeni syndrome Untested pt w BRCA 1st deg relative6 Self 1st deg relative w Li Fraumeni Cowden BRR syndromes6 Patient Type Detail Header (Long) <b>High-risk screening criteria:</b>